Skip to main content

Table 2 Multivariate analysis for PFS

From: Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy

  P Value 95% CI
Lower Upper
Bevacizumab administration .275 .466 1.243
ECOG score .323 .355 1.406
Surgery .001 1.704 6.973
Age > 65 .413 .769 1.893
NLR .903 .618 1.724
FIGO stage .229 .836 1.044